Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose-Response Relationship,Drug”

99 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 99 results

Early research (Phase 1)Study completedNCT00001010
What this trial is testing

Zidovudine Plus Acyclovir in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 72
Testing effectiveness (Phase 2)Study completedNCT00002239
What this trial is testing

Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults

Who this might be right for
HIV Infections
Hoffmann-La Roche 68
Early research (Phase 1)Study completedNCT00006325
What this trial is testing

Safety, Tolerability, and Anti-HIV Activity of PEG-Intron in HIV-Positive Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 54
Early research (Phase 1)Study completedNCT00002214
What this trial is testing

Phase I Trial of S-1153 in Patients With HIV Infection

Who this might be right for
HIV Infections
Lexigen Pharmaceuticals 40
Large-scale testing (Phase 3)Looking for participantsNCT06740214
What this trial is testing

Analgesic Efficacy of Different Liposomal Bupivacaine Doses in the Adductor Canal Block for Total Knee Arthroplasty

Who this might be right for
Pain, PostoperativeAnalgesic EffectTotal Knee Arthroplasty+2 more
The University of Hong Kong 177
Testing effectiveness (Phase 2)UnknownNCT00002219
What this trial is testing

Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children

Who this might be right for
HIV Infections
Gilead Sciences 36
Not applicableStudy completedNCT00302913
What this trial is testing

Efficacy of Adjusted Clopidogrel Dose in Patients With Insufficient Platelet Inhibition

Who this might be right for
Coronary Artery DiseaseDrug Resistance
University Heart Center Freiburg - Bad Krozingen 120
Early research (Phase 1)Study completedNCT00000729
What this trial is testing

Study To Determine Foscarnet Dose Response in HIV Infected Patients With PGL and/or Constitutional Disease

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 10
Testing effectiveness (Phase 2)Study completedNCT00000948
What this trial is testing

Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 72
Post-approval studies (Phase 4)UnknownNCT02781246
What this trial is testing

Effect of Perineural Dexmedetomidine on the ED50 Ropivacaine for Brachial Plexus Blocks in Pediatric Patients: a Randomized Trial

Who this might be right for
Dose-Response Relationship, Drug
Guangzhou Women and Children's Medical Center 160
Early research (Phase 1)Study completedNCT00006066
What this trial is testing

Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 92
Testing effectiveness (Phase 2)Study completedNCT00002322
What this trial is testing

Different Doses of Atevirdine Mesylate Plus Zidovudine in HIV-Positive Patients

Who this might be right for
HIV Infections
Pharmacia and Upjohn
Large-scale testing (Phase 3)Study completedNCT00000949
What this trial is testing

Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 460
Early research (Phase 1)Study completedNCT00029900
What this trial is testing

ADI-PEG in Patients With Metastatic Melanoma

Who this might be right for
MelanomaNeoplasm Metastasis
FDA Office of Orphan Products Development 15
Early research (Phase 1)Study completedNCT00069030
What this trial is testing

Safety of and Immune Response to an HIV Vaccine (VRC-HIVDNA009-00-VP) Administered With Interleukin-2/Immunoglobulin (IL-2/Ig) DNA Adjuvant in Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 70
Testing effectiveness (Phase 2)Study completedNCT00029874
What this trial is testing

Minocycline in Patients With Huntington's Disease

Who this might be right for
Huntington's Disease
FDA Office of Orphan Products Development 63
Early research (Phase 1)Study completedNCT00000725
What this trial is testing

A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 56
Early research (Phase 1)Study completedNCT00001108
What this trial is testing

The Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 6
Early research (Phase 1)Study completedNCT00002403
What this trial is testing

Safety and Effectiveness of Zintevir (AR177) Given to HIV-Infected Patients

Who this might be right for
HIV Infections
Aronex Pharmaceuticals 12
Not applicableStudy completedNCT00002385
What this trial is testing

The Safety and Effectiveness of Fozivudine Tidoxil in HIV-1 Infected Patients

Who this might be right for
HIV Infections
Anderson Clinical Research 60
Load More Results